| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Letermovir | 0.77 | No resistance | Clinical Isolate | Details | Phenotypes of cytomegalovirus genetic variants encountered in a letermovir clinical trial illustrate the importance of genotyping validation. (Aug 2024) |
| Mutant | Resistances |
|---|---|
| M329T |
Letermovir:
|